The AARG-D grant program aims to fund early-career investigators who are less than 15 years past their doctoral degree or post-residency (M.D. or D.O.) with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to federal or other funding entities.
The objective of this award is to increase the number of highly trained investigators from diverse backgrounds whose basic, clinical and social/behavioral research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to Alzheimer's and all other dementias in general and in health disparities populations. The Alzheimer's Association recognizes the need to increase the number of scientists from underrepresented groups participating in biomedical and behavioral research. We anticipate that by providing these research opportunities, the number of scientists from underrepresented groups entering and remaining in biomedical research careers in Alzheimer's and all other dementia will increase.
This grant is open to U.S. and international researchers.
The Alzheimer's Association Research Grant to Promote Diversity (AARG-D) award is up to three years (minimum two years) to increase the number of scientists from underrepresented groups at academic institutions in Alzheimer’s or all other dementia research.
The objective of this award is to increase the number of highly trained investigators from diverse backgrounds whose basic, clinical and social/behavioral research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to Alzheimer's and all other dementias in general and in health disparities populations. The Alzheimer's Association recognizes the need to increase the number of scientists from underrepresented groups participating in biomedical and behavioral research. The Association anticipates that by providing these research opportunities, the number of scientists from underrepresented groups entering and remaining in biomedical research careers in Alzheimer's and all other dementia will increase.
The purpose of this program is to provide new scientists from underrepresented groups with funding that will allow them to develop preliminary or pilot data, to test procedures and to develop hypotheses. The intent is to support early-career development that will lay the groundwork for future research grant applications to federal and other funding agencies.
The mechanism of this award is the individual research grant. The Alzheimer's Association recognizes the need to increase the number of scientists from underrepresented groups in the research enterprise for Alzheimer's and all other dementia. Young scientists from these groups are encouraged to apply.
Each AARG-D award total is limited to $200,000 (direct and indirect costs) for up to three years (Award should be a minimum 2 years. For a 2 year award the total is limited to $140,000 with direct and indirect costs). Requests may not exceed $70,000 in any given year (direct and indirect costs). Indirect costs are capped at 10 percent of total direct costs and are inclusive of indirect costs for the implementing institution as well as to any subcontracts.
Letter of Intent deadline: February 27, 2025, 5 p.m. ET
Each AARG-D LOI is evaluated with attention to:
Letter of Intent notifications: Week of March 31, 2025
Note: due to the high volume of submissions, specific feedback and reviewer comments are not provided at the LOI stage.
Application deadline: May 1, 2025, 5 p.m. ET
If invited to submit a full application, each AARG-D application is evaluated on:
Award notifications: Prior to August 30, 2025
A “budget summary” for the proposed research project is required and must be submitted with the application and within the allowable two-page limit. However, if the application is to be awarded, a more detailed budget will be required and must be approved before the disbursement of funds.
Allowable costs under this award
It is required that most of the funds awarded under this program be used for direct research support. No more than 10% of the total direct costs may be included as indirect costs; this is inclusive of indirect costs for the implementing institution as well as any to subcontracts.
Allowable costs include:
Direct costs not allowed under this award
Direct costs not allowed include:
Please see Section III, J: Reporting Requirements for additional details.
This award requires:
Note: The continuation of the grant over the awarded duration is contingent upon the timely receipt of all required reports.
For any inquires or additional information, please contact a member of the Alzheimer’s Association Grants staff at grantsapp@alz.org.
Applicants must be an Assistant Professors or Associate Professor at their respective academic institution and less than 15 years past their doctoral degree or post-residency (M.D. or D.O.).
Specific for the AARG-D program, eligible applicants have the same requirements as the AARG program, but are an underrepresented faculty in biomedical and behavioral research on a national, international or institutional basis. The world’s low and middle income countries (LMICs) are a diverse group by size, population, and income level. Researchers from these countries are encouraged to apply.
Applicants must submit a Diversity Self Statement (one paragraph max.) during the letter of intent (LOI) stage outlining the applicant’s status and eligibility for this program.
Additional details regarding what may be defined as underrepresented include:
Any questions related to eligibility, please contact the Alzheimer's Association at grantsapp@alz.org prior to submitting an LOI. No exceptions will be made after the LOI deadline has passed. The Alzheimer’s Association reserves the right to require additional documentation if necessary.
The self-statement will not be included in the information shared with reviewers and will only be used to confirm eligibility to this program. This statement will only be accessible to the applicant and the Alzheimer’s Association through their Proposal Central Account (if the applicant gives others access to the LOI, they will be able to view all attachments).
Note: Alzheimer’s Association grants are generally open to scientists and researchers across the globe; however, as a U.S.-based charity, the Alzheimer’s Association is subject to, and complies with, U.S. law. As a result, the Alzheimer’s Association cannot award, and will not award, grants in violation of applicable U.S. statutes and regulations. This means, among other things, that the Alzheimer’s Association cannot, and will not, fund any individual or entity (i) that is subject to U.S. comprehensive or targeted sanctions or if awarding funding would result in a violation of such sanctions, (ii) that is on the U.S. List of Specially Designated Nationals or entities owned or controlled by such persons, or (iii) when doing so is otherwise prohibited by U.S. laws related to combating terrorism.
Sponsor Institute/Organizations: Alzheimer’s Association
Sponsor Type:
Address: 225 N Michigan Ave. Floor 17 Chicago, IL 60601 800.272.3900
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Feb 27, 2025
May 01, 2025
$200,000
Affiliation: Alzheimer’s Association
Address: 225 N Michigan Ave. Floor 17 Chicago, IL 60601 800.272.3900
Website URL: https://www.alz.org/research/for_researchers/grants/types-of-grants/aarg-d
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.